Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells

Cancer Letters

Volumn 237, Issue 1, 2006, Pages 33-44

  Kang, Yun Hee ^a,b   Lee, Kyung Ae ^a   Ryu, Chun Jeih ^a   Lee, Hee Gu ^a   Lim, Jong Seok ^a   Park, Sue Nie ^c   Paik, Sang Gi ^b   Yoon, Do Young ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Korea Food and Drug Administration   (South Korea)

Author keywords

Apoptosis; Caspase 8; Cervical carcinoma cells; FasL; Interleukin 18; Mitomycin C

Indexed keywords

CARBOPLATIN; CASPASE 3; CASPASE 8; CISPLATIN; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; MITOMYCIN C; PROTEIN E6; PROTEIN P53; SYNAPTOTAGMIN;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NICK END LABELING; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; UTERINE CERVIX CARCINOMA;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; FAS LIGAND PROTEIN; FEMALE; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-18; MEMBRANE GLYCOPROTEINS; MITOMYCIN; ONCOGENE PROTEINS, VIRAL; RECEPTORS, TUMOR NECROSIS FACTOR; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTORS; UTERINE CERVICAL NEOPLASMS;

RICE STRIPE VIRUS;

EID: 33646496166     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.05.043     Document Type: Article

References (42)

1. Scheffner M., Munger K., Byrne J.C., and Howley P.M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl Acad. Sci. USA 88 (1991) 5523-5527
2. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., et al. Role of a p53 polymorphism in the development of human papillomavirus- associated cancer. Nature 393 (1998) 229-234
3. Lechner M.S., and Laimins L.A. Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J. Virol. 68 (1994) 4262-4273
4. Beer-Romero P., Glass S., and Rolfe M. Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 14 (1997) 595-602
5. Gutierrez M.L., and Crooke S.T. Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine-dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C. Cancer Treat. Rev. 6 (1979) 153-164
6. Hata T., and Sugawara R. Mitomycin, a new antibiotic from Streptomyces. II. Description of the strain. J. Antibiot. 9 (1956) 147-151
7. Wakaki S., Marumo H., Tomioka K., Shimizu M., Kato E., Kamada H., et al. Purification and isolation study on gancidins. J. Antibiot. (Tokyo) 11 (1958) 150-155
8. Iyer V.N., and Szybalski W. Mitomycins and porfiromycin: chemical mechanism of activation and cross-linking of DNA. Science 145 (1964) 55-58
9. Weissbach G. Effects of combined treatment of infantile toxoplasmosis with pyrimethamine (daraprim) and sulfonamides on the blood and bone marrow. Z. Arztl. Fortbild. (Jena) 59 (1965) 10-22
10. Bachur N.R., Steele M., Meriwether W.D., and Hildebrand R.C. Cellular pharmocodynamics of several anthrocycline antibiotics. J. Med. Chem. 19 (1976) 651-654
11. Gusev V.A., and Panchenko L.F. Superoxide radical and superoxide dismutase in the free-radical theory of aging. Vopr. Med. Khim. 28 (1982) 8-25 (a review)
12. Hashimoto Y., Shudo K., and Okamoto T. Alkylation of DNA with a mitomycin derivative, 7-N-(p-hydroxyphenyl)-mitomycin C. Reductive alkylation nd preferential binding to adenine. Chem. Pharm. Bull. (Tokyo) 30 (1982) 2644-2646
13. Doroshow J.H. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc. Natl Acad. Sci. USA 83 (1986) 4514-4518
14. Sartorelli A.C. The role of mitomycin antibiotics in the chemotherapy of solid tumors. Biochem. Pharmacol. 35 (1986) 67-69
15. Sartorelli L., Mantovani G., and Ciman M. Carnitine and deoxycarnitine concentration in rat tissues and urine after their administration. Biochim. Biophys. Acta 1006 (1989) 15-18
16. Balis M.E. Seminars on Lesch-Nyhan syndrome. Aspects of purine metabolism. Fed. Proc. 27 (1968) 1067-1074
17. Kang Y.H., Kang M.J., Paik S.G., Park S.N., and Yoon D.Y. Repression of HPV E6-activated RSV promoter activity by anti-cancer agents. Antivir. Res. 58 (2003) 65-71
18. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119 (1992) 493-501
19. Zou A.P., Cheng G., Pi Y.Q., Wang W.H., Yu S.B., and Wang D.X. The role of lipoxygenase and cyclooxygenase metabolites in acute hypoxic pulmonary vasoconstriction in piglets. J. Tongji. Med. Univ. 9 (1989) 239-243
20. Juntti-Berggren L., Larsson O., Rorsman P., Ammala C., Bokvist K., Wahlander K., et al. Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes. Science 261 (1993) 86-90
21. Wei H., and Perry D.C. Dantrolene is cytoprotective in two models of neuronal cell death. J. Neurochem. 67 (1996) 2390-2398
22. Muller F., Giroglou T., and Sapp M. Characterization of the DNA-binding activity of the E1 and E2 proteins and the E1/E2 complex of human papillomavirus type 33. J. Gen. Virol. 78 (1997) 911-915
23. Fulda S., Sieverts H., Friesen C., Herr I., and Debatin K.M. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57 (1997) 3823-3829
24. Friesen C., Herr I., Krammer P.H., and Debatin K.M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2 (1996) 574-577
25. Sun S.Y., Yue P., Wu G.S., El-Deiry W.S., Shroot B., Hong W.K., et al. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res. 59 (1999) 2829-2833
26. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68 (1999) 383-424
27. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell. Dev. Biol. 15 (1999) 269-290
28. Ferrera A., Velema J.P., Figueroa M., Bulnes R., Toro L.A., Claros J.M., et al. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study. Int. J. Cancer. 82 (1999) 799-803
29. Borner M.M., Myers C.E., Sartor O., Sei Y., Toko T., Trepel J.B., et al. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res. 55 (1995) 2122-2128
30. Strasser A., Harris A.W., Jacks T., and Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79 (1994) 329-339
31. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
32. Strasser A., Harris A.W., Huang D.C., Krammer P.H., and Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. Eur. Mol. Biol. Org. J. 14 (1995) 6136-6147
33. Newton K., and Strasser A. Cell death control in lymphocytes. Adv. Immunol. 76 (2000) 179-226
34. Wesselborg S., Engels I.H., Rossmann E., Los M., and Schulze-Osthoff K. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93 (1999) 3053-3063
35. Villunger A., Egle A., Kos M., Hartmann B.L., Geley S., Kofler R., et al. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cel. Cancer Res. 57 (1997) 3331-3334
36. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., and Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391 (1998) 43-50
37. Liu C., Si J., Liu S., Xu X., and Song G. Cloning of human papillomavirus type 16 E7 gene and expression in E. coli. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 20 (1998) 168-172
38. Yang X.H., Sladek T.L., Liu X., Butler B.R., Froelich C.J., and Thor A.D. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res 61 (2001) 348-354
39. Pirnia F., Schneider E., Betticher D.C., and Borner M.M. Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ. 9 (2002) 905-914
40. Dao T., Ohashi K., Kayano T., Kurimoto M., and Okamura H. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell. Immunol. 173 (1996) 230-235
41. Ohtsuki T., Micallef M.J., Kohno K., Tanimoto T., Ikeda M., and Kurimoto M. Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res 17 (1997) 3253-3258
42. Chandrasekar B., Vemula K., Surabhi R.M., Li-Weber M., Owen-Schaub L.B., Jensen L.E., et al. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. J. Biol. Chem. 279 (2004) 20221-20233